Quantinuum raises $1.68bn in Nasdaq IPO at $14bn, quantum computing's first major public listing

Summary

Quantinuum, the full-stack quantum computing company 54%-owned by Honeywell, raised $1.68bn in its Nasdaq IPO on 4 June 2026, pricing 28 million Class A shares at $60 each, upsized from its original plan. The stock rose 13.3% on its first day of trading, reaching a $17.6bn market capitalisation and making Quantinuum the most valuable quantum computing company ever to go public. The company was formed in 2021 from the merger of Honeywell Quantum Solutions, which builds trapped-ion quantum computers, and Cambridge Quantum Computing, which develops algorithms and software. Its S-1 disclosed FY2025 revenue of $30.9m, up 35% year-over-year, against a net loss of $192.6m and R&D spending of $165.4m. At the IPO price, the company traded at 453x trailing revenue, the highest multiple of any US tech IPO in 2026. Customers include Airbus, BMW, JPMorgan Chase and Amgen. The company has offices in the US, UK, Germany, Japan, Qatar and Singapore, and holds a strategic MOU with Mitsubishi Electric for industrial quantum applications. OpenAI and Anthropic are pursuing confidential IPO filings in the same window, making 2026 the most significant year for tech public listings since 2021.

The split

US financial press focuses on the valuation multiple, which is the highest of any tech listing this year and reflects a bet on quantum advantage, not near-term earnings. Specialist quantum outlets (The Quantum Insider) frame the IPO as validating two decades of investment in trapped-ion hardware, noting that Quantinuum's error-correction results are the best published. Japanese coverage emphasises the Mitsubishi MOU as evidence that industrial corporates in Asia are preparing quantum-ready supply chains before advantage is proven. The critical view: European deep-tech funds and some US analysts note that $453x revenue multiple implies fault-tolerant quantum computing within 3-5 years, a timeline that most academic labs consider optimistic.

By the numbers

• $1.68bn, IPO proceeds after over-allotment.
• $60, IPO price per share (28 million Class A shares).
• $14bn, implied market cap at IPO price.
• $17.6bn, market cap after first-day 13.3% gain.
• $30.9m, FY2025 revenue (+35% YoY).
• $192.6m, FY2025 net loss.
• 453x, price-to-revenue multiple at IPO.
• 54%, Honeywell's post-IPO stake.

Why it matters

Quantinuum's IPO is the first test of whether public markets will price quantum computing before revenue scales. The 453x revenue multiple sets a benchmark for Deeptech companies with long-cycle hardware roadmaps, opening the door for Pasqal (which is pursuing a SPAC listing at $2bn) and PsiQuantum to follow. Honeywell retaining 54% means the parent's quantum conviction stays fully on the table, reducing the risk of a seller overhang. If QNT holds near or above its debut price through the first quarterly earnings, it resets what public investors are willing to pay for pre-revenue deep tech.

What to watch

• First quarterly earnings as a public company, with market scrutiny on the revenue growth rate vs. the net-loss trajectory.
• Whether Honeywell reduces its 54% stake via a secondary offering.
• Pasqal's SPAC listing timeline and whether it prices above or below Quantinuum's implied comps.
• Progress toward fault-tolerant qubits, the inflection point that would justify the IPO multiple.

---